Back to GetFilings.com



Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 10-Q
 
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 29, 2002.
 
OR
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                          to                         
 
Commission File Number: 000-30615
 

 
SIRENZA MICRODEVICES, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
77-0073042
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
522 Almanor Avenue, Sunnyvale, CA
 
94085
(Address of principal executive offices)
 
(Zip Code)
 
(408) 616-5400
(Registrant’s telephone number, including area code)
 
(Former name, former address and former fiscal year, if changed since last report)
 

 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) had been subject to such filing requirements for the past 90 days. Yes  x    No  ¨
 
As of October 27, 2002, there were 29,814,426 shares of registrant’s Common Stock outstanding.
 


Table of Contents
SIRENZA MICRODEVICES, INC.
 
INDEX
 
         
Page

Part I.  Financial Information
    
        Item 1.
     
1
        Item 2.
     
17
        Item 3.
     
50
        Item 4.
     
51
Part II.  Other Information
    
        Item 1.
     
51
        Item 2.
     
52
        Item 3.
     
52
        Item 4.
     
52
        Item 5.
     
52
        Item 6.
     
53
  
53
  
54


Table of Contents
Part I.  Financial Information
 
Item 1.  Financial Statements
 
Sirenza Microdevices, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
 
    
September 30, 2002

    
December 31, 2001

 
    
(unaudited)
        
Assets
                 
Current assets:
                 
Cash and cash equivalents
  
$
2,278
 
  
$
15,208
 
Short-term investments
  
 
18,032
 
  
 
27,118
 
Accounts receivable, net
  
 
1,831
 
  
 
1,158
 
Inventories
  
 
2,248
 
  
 
1,894
 
Other current assets
  
 
1,056
 
  
 
1,062
 
    


  


Total current assets
  
 
25,445
 
  
 
46,440
 
Property and equipment, net
  
 
7,073
 
  
 
7,285
 
Long-term investments
  
 
16,593
 
  
 
9,058
 
Investment in GCS
  
 
7,500
 
  
 
—  
 
Intangible and other assets
  
 
1,058
 
  
 
1,260
 
Goodwill
  
 
834
 
  
 
—  
 
    


  


Total assets
  
$
58,503
 
  
$
64,043
 
    


  


Liabilities and stockholders’ equity
                 
Current liabilities:
                 
Accounts payable
  
$
2,009
 
  
$
1,464
 
Accrued expenses
  
 
2,184
 
  
 
1,745
 
Deferred margin on distributor inventory
  
 
2,035
 
  
 
3,631
 
Accrued restructuring
  
 
1,916
 
  
 
2,155
 
Capital lease obligations, current portion
  
 
593
 
  
 
634
 
    


  


Total current liabilities
  
 
8,737
 
  
 
9,629
 
Capital lease obligations and other long-term liabilities
  
 
154
 
  
 
401
 
Stockholders’ equity
                 
Common Stock
  
 
30
 
  
 
30
 
Additional paid-in capital
  
 
128,862
 
  
 
128,426
 
Deferred stock compensation
  
 
(996
)
  
 
(1,787
)
Accumulated deficit
  
 
(78,119
)
  
 
(72,656
)
Treasury stock, at cost
  
 
(165
)
  
 
—  
 
    


  


Total stockholders’ equity
  
 
49,612
 
  
 
54,013
 
    


  


Total liabilities and stockholders’ equity
  
$
58,503
 
  
$
64,043
 
    


  


 
See accompanying notes.


Table of Contents
 
Sirenza Microdevices, Inc.
Condensed Consolidated Statements Of Operations
(In thousands, except per share data)
(unaudited)
 
    
Three Months Ended

    
Nine Months Ended

 
    
September 30, 2002

    
September 30, 2001

    
September 30, 2002

    
September 30, 2001

 
Net revenues
  
$
5,206
 
  
$
3,188
 
  
$
14,939
 
  
$
16,343
 
Cost of revenues (exclusive of amortization of deferred stock compensation of $48, $110, $32 and $106 for the three and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively)
  
 
2,401
 
  
 
7,468
 
  
 
6,022
 
  
 
15,084
 
    


  


  


  


Gross profit (loss)
  
 
2,805
 
  
 
(4,280
)
  
 
8,917
 
  
 
1,259
 
Operating expenses:
                                   
Research and development (exclusive of amortization of deferred stock compensation of $65, $161, $61 and $204 for the three and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively)
  
 
1,889
 
  
 
3,116
 
  
 
4,945
 
  
 
7,619
 
Sales and marketing (exclusive of amortization of deferred stock compensation of $75, $195, $65 and $216 for the three and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively)
  
 
1,244
 
  
 
1,365
 
  
 
3,675
 
  
 
4,419
 
General and administrative (exclusive of amortization of deferred stock compensation of $125, $325, $314 and $621 for the three and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively)
  
 
1,241
 
  
 
1,111
 
  
 
3,622
 
  
 
3,340
 
Amortization of deferred stock compensation
  
 
313
 
  
 
472
 
  
 
791
 
  
 
1,147
 
In-process research and development
  
 
2,200
 
  
 
—  
 
  
 
2,200
 
  
 
—  
 
Restructuring
  
 
(112
)
  
 
—  
 
  
 
(112
)
  
 
—  
 
    


  


  


  


Total operating expenses
  
 
6,775
 
  
 
6,064
 
  
 
15,121
 
  
 
16,525
 
    


  


  


  


Loss from operations
  
 
(3,970
)
  
 
(10,344
)
  
 
(6,204
)
  
 
(15,266
)
Interest expense
  
 
13
 
  
 
26
 
  
 
48
 
  
 
99
 
Interest income and other, net
  
 
245
 
  
 
1,086
 
  
 
789
 
  
 
3,153
 
    


  


  


  


Loss before taxes
  
 
(3,738
)
  
 
(9,284
)
  
 
(5,463
)
  
 
(12,212
)
Provision for income taxes
  
 
—  
 
  
 
3,154
 
  
 
—  
 
  
 
2,276
 
    


  


  


  


Net loss
  
$
(3,738
)
  
$
(12,438
)
  
$
(5,463
)
  
$
(14,488
)
    


  


  


  


Net loss per share
                                   
Basic
  
$
(0.13
)
  
$
(0.42
)
  
$
(0.18
)
  
$
(0.50
)
    


  


  


  


Diluted
  
$
(0.13
)
  
$
(0.42
)
  
$
(0.18
)
  
$
(0.50
)
    


  


  


  


Shares used to compute net loss per share
                                   
Basic
  
 
29,869
 
  
 
29,447
 
  
 
29,837
 
  
 
28,996
 
    


  


  


  


Diluted
  
 
29,869
 
  
 
29,447
 
  
 
29,837
 
  
 
28,996
 
    


  


  


  


 
See accompanying notes.


Table of Contents
 
Sirenza Microdevices, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(unaudited)
 
      
Nine Months Ended

 
      
September 30, 2002

      
September 30, 2001

 
Operating Activities
                     
Net loss
    
$
(5,463
)
    
$
(14,488
)
Adjustments to reconcile net loss to net cash used in operating activities:
                     
Depreciation and amortization
    
 
2,136
 
    
 
2,091
 
Deferred tax assets
    
 
—  
 
    
 
2,277
 
Retirement of property and equipment
    
 
56
 
    
 
—  
 
Abandoned and impaired equipment
    
 
—  
 
    
 
1,468
 
Amortization of deferred stock compensation
    
 
791
 
    
 
1,147
 
In-process research and development
    
 
2,200
 
    
 
—  
 
Changes in operating assets and liabilities:
                     
Accounts receivable
    
 
(519
)
    
 
2,500
 
Inventories
    
 
(208
)
    
 
5,039
 
Other assets
    
 
(138
)
    
 
572
 
Accounts payable
    
 
348
 
    
 
(495
)
Accrued expenses
    
 
56